Your search returned 10 results.

Results
	1.	[Clinical trials in oncology: specific methodology problems]. [electronic resource] by Baumelou, E Méry-Mignard, D Lehner, J P Producer: 20021210 In: Therapie vol. 57 Availability: No items available. Save to lists Add to cart (remove)
	2.	An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors. [electronic resource] by Ychou, M Conroy, T Seitz, J F Gourgou, S Hua, A Mery-Mignard, D Kramar, A Producer: 20040227 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Antitumour activity of three second-line treatment combinations in patients with metastatic colorectal cancer after optimal 5-FU regimen failure: a randomised, multicentre phase II study. [electronic resource] by Rougier, P Lepille, D Bennouna, J Marre, A Ducreux, M Mignot, L Hua, A Méry-Mignard, D Producer: 20030418 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trials. [electronic resource] by Mitry, E Douillard, J-Y Van Cutsem, E Cunningham, D Magherini, E Mery-Mignard, D Awad, L Rougier, P Producer: 20041202 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high-dose leucovorin every two weeks (LV5FU2 regimen): a clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancer. [electronic resource] by Ducreux, M Ychou, M Seitz, J F Bonnay, M Bexon, A Armand, J P Mahjoubi, M Méry-Mignard, D Rougier, P Producer: 20000105 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	A phase I-II, dose-escalating trial of ZD9331 in combination with irinotecan (CPT11) in previously pretreated metastatic colorectal cancer patients. [electronic resource] by Louvet, C André, T Gamelin, E Garcia, M-L Saavedra, A Lenaers, G de Gramont, A Méry-Mignard, D Kalla, S Producer: 20050114 In: Bulletin du cancer vol. 91 Availability: No items available. Save to lists Add to cart (remove)
	7.	Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors. [electronic resource] by Macaulay, V M Middleton, M R Protheroe, A S Tolcher, A Dieras, V Sessa, C Bahleda, R Blay, J-Y LoRusso, P Mery-Mignard, D Soria, J-C Producer: 20130730 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: results of two independent phase I studies with pharmacokinetics. [electronic resource] by Wasserman, E Cuvier, C Lokiec, F Goldwasser, F Kalla, S Méry-Mignard, D Ouldkaci, M Besmaine, A Dupont-André, G Mahjoubi, M Marty, M Misset, J L Cvitkovic, E Producer: 20000113 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial. [electronic resource] by Coudert, B P Arnould, L Moreau, L Chollet, P Weber, B Vanlemmens, L Moluçon, C Tubiana, N Causeret, S Misset, J-L Feutray, S Mery-Mignard, D Garnier, J Fumoleau, P Producer: 20060927 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	A phase I clinical and pharmacokinetic study of capecitabine (Xeloda) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours. [electronic resource] by Delord, J P Pierga, J Y Dieras, V Bertheault-Cvitkovic, F Turpin, F L Lokiec, F Lochon, I Chatelut, E Canal, P Guimbaud, R Mery-Mignard, D Cornen, X Mouri, Z Bugat, R Producer: 20050421 In: British journal of cancer vol. 92 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)